Similar Articles
271 SIBLINGs and SPARC families: Their emerging roles in pancreatic cancer
272 Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells
273 Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology
274 Improving outcomes in pancreatic cancer: Key points in perioperative management
275 Synchronous gallbladder and pancreatic cancer associated with pancreaticobiliary maljunction
276 S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer
277 Biomarkers for pancreatic cancer: Recent achievements in proteomics and genomics through classical and multivariate statistical methods
278 Gene therapy in pancreatic cancer
279 Nuclear receptors and pathogenesis of pancreatic cancer
280 Therapeutic options for the management of pancreatic cancer
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA